Skip to ContentSkip to Navigation
Practical matters How to find us prof. dr. A.A. (Adriaan) Voors


Additional burden of iron deficiency in heart failure patients beyond the cardio-renal anaemia syndrome: findings from the BIOSTAT-CHF study

A First-in-Human Study of AMG 986, a Novel Apelin Receptor Agonist, in Healthy Subjects and Heart Failure Patients

Albuminuria as a marker of systemic congestion in patients with heart failure( )

Assessment of Proximal Tubular Function by Tubular Maximum Phosphate Reabsorption Capacity in Heart Failure

A Systematic Review and Network Meta-Analysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction

Atrial function in paroxysmal AF patients with and without heart failure with preserved ejection fraction: Data from the AF-RISK study

Bending oxygen saturation index and risk of worsening heart failure events in chronic heart failure

Biomarker changes as surrogate endpoints in early-phase trials in heart failure with reduced ejection fraction

Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of Cardiology

Changes in Right Ventricular–to–Pulmonary Artery Coupling After Transcatheter Edge-to-Edge Repair in Secondary Mitral Regurgitation

Read more


Novità nel trattamento dello scompenso cardiaco acuto

Benefits of Empagliflozin Proves Greater Than Placebo for Those With Acute Heart Failure

Empagliflozin benefits adults hospitalised for acute heart failure, shows study

Jardiance helps adults following acute heart failure

EMPULSE shows empagliflozin benefit in acute heart failure

Journal of Cardiac Failure Launches Rapid Publication Platform to Spark Discourse

Health Care Reimbursement May Affect SGLT2 Inhibitor Uptake

Read more